Agno Pharma Company Profile
Agno Pharma is a global GMP compliant contract manufacturer jointly formed between Pharmalytica Services (a US-based company) and Keylab (a China-based company). Our mission is to provide timely and quality intermediates and APIs to our pharmaceutical and chemical clients throughout the world. Our company is founded upon our belief in the synergistic merger of US pharmaceutical manufacturing technologies, management, product registration and GMP compliance with China's economical manufacturing capabilities. This synergistic joint-venture allows us to provide the highest quality intermediates and GMP compliant APIs to our clients in a timely manner that is extremely cost competitive.
Our US partner, Pharmalytica Services, is an FDA-registered and DEA-licensed GMP compliant laboratory.
Pharmalytica Services has been providing outstanding GMP compliant laboratory and consulting services to major US and European pharmaceutical and chemical companies since the year 2000.
Our Chinese partner, Keylab, is an ISO 9001/14000 company. Keylab has been providing quality intermediates to US, European and Asian pharmaceutical and chemical companies since 1995
Location
683 N.Mountain Road
Newington
Connecticut
6111
United States of America
Contact
Phone: 1-860-953-2219
Fax: 1-860-953-2221
Email: info@agnopharma.com
News Articles
Pharma 3.0 Pulls Companies into the Digital Future
Social media and mobile marketing have kick-started the pharma industry into a phase dubbed Pharma 3.0. Gone are the days of Pharma 1.0 in which companies could rely on a handful of blockbuster drug...
Big pharma companies BMS and Merck are pharma partnering on Daclatasvir
Big pharma company, Bristol-Myers Squibb, is pharma partnering with another big pharma company, Merck, to develop Daclatasvir to treat Hepatitis C. The big pharma companies will work on the hepatitis...
Merck enter pharma partnering pact with Ra Pharma for cyclomimetics
Ra Pharmaceuticals has entered into a pharma partnering deal with Merck, a top 50 big pharma corporation, focused on the development of Cyclomimetics, a new class of compounds that have the diversity...
Verona Pharma plc: Analyst Presentation on the Company Website
LONDON, April 10, 2013 /PRNewswire/ -- Verona Pharma plc ("Verona Pharma" or the "Company") Verona Pharma plc (VRP: London Stock Exchange) ("Verona Pharma", or the "Company"), the biotechnology co...
Big Pharma performance continues to receive muted reviews from various analysts and industry commentators. Pharma Reform starts with an analysis of drug approvals in 2012 by FDA. It is TRUE that 35 dr...
Bad Pharma by Dr Ben Goldacre; the mechanics of a mediocre argument
Nick Broughton discusses Dr Ben Goldacre’s latest book, Bad Pharma, and comments on why he believes it was a wasted opportunity for the pharma industry. If you are working in pharma and are not awa...
Pharma IQ’s Top Pharma Bloggers of 2013
Pharma IQ put out it’s list of the Top Pharma Bloggers for 2013. These lists tend to be subjective and always leave off many great sites. But, these can be a good way to discover a blog you have...
Catalent and UMN Pharma Announce Collaboration for Biosimilar Development and Production in Japan
Catalent Pharma Solutions and UMN Pharma Inc. today announced the signing of an agreement to provide UMN Pharma a broad range of biosimilar cell lines using Catalent’s proprietary GPEx ® techno...
Drugs and Medications
Fluoride [Libertas Pharma, Inc.]
Fluoride Chewable Tablets 0.5 mg
Fluoride [Libertas Pharma, Inc.]
Fluoride Chewable Tablets 1 mg
Metoprolol tartrate [Med-Health Pharma, LLC]
Metoprolol Tartrate Tablets, USP
Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )
Eloxatin [Aventis Pharma Ltd.]
NA
PubMed Articles
Limit-test toxicity screening of selected inorganic nanoparticles to the earthworm Eisenia fetida.
The toxicity of a range of inorganic (Ag, Cu, Ni, Al(2)O(3), SiO(2), TiO(2) and ZrO(2)) nanoparticles (NP) and their corresponding metal salt or bulk metal oxide were screened for toxicity toward the...
Objectives The in vitro pharmacodynamics of silver(I) and silver(II) complexes of a polydiguanide ligand, chlorhexidine, were assayed to examine the value of the bactericidal endpoint as an alternativ...
Plant regeneration and transformation in vitro is often improved by adding silver ion (Ag(+)) to the culture media as AgNO(3) or silver thiosulfate (STS). Ag(+) reacts with substances to form insolubl...
Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One o...
Clinical Trials
To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.
Pharma-Pen (Formerly Innoject) Auto-Injectory TIV
The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...
To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions
To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.
This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...
Development of a New Method for Analgesia
Aim: To examine a new method to perform local anesthesia in order to diminish the inconvenience by the procedure in patients before performing intubation or oesophagogastroduodenoscopy.
Companies
Agno Pharma is a global GMP compliant contract manufacturer jointly formed between Pharmalytica Services (a US-based company) and Keylab (a China-based company). Our mission is to provide timely and...
H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and...
LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...
Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies,...
FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...
More Information about "Agno Pharma" on BioPortfolio
We have published hundreds of Agno Pharma news stories on BioPortfolio along with dozens of Agno Pharma Clinical Trials and PubMed Articles about Agno Pharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Agno Pharma Companies in our database. You can also find out about relevant Agno Pharma Drugs and Medications on this site too.